{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-033942","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2026-07-20T21:20:17+00:00","discovered_at":"2026-07-20T21:22:00.271084+00:00","generated_at":"2026-07-20T21:22:03.909327+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aspire Biopharma clarifies warrant terms after two reverse splits; exercise price now $13,800","bullets":["Original exercise price of $11.50 per share adjusted to $13,800 after 1-for-30 and 40-1 reverse splits.","Warrant ratio changed to 1,200 warrants to purchase one share of common stock.","Reverse splits effective January 16, 2026 and May 11, 2026.","Clarification provided in response to requests from public warrant holders.","Warrants trade under symbol ASBPW on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-033942","json":"https://secwatch.observer/filing/0001493152-26-033942.json","markdown":"https://secwatch.observer/filing/0001493152-26-033942.md","text":"https://secwatch.observer/filing/0001493152-26-033942.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226033942/0001493152-26-033942-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000149315226033942/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-20T21:22:03.909327+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}